A2P2™

Product-lifetime evidence, built from the material—not an assumption.

A2P2 is the patented enterprise framework and live platform for mechanism-driven accelerated ageing. It gives R&D, quality and regulatory teams a faster, traceable route from material behaviour to a defensible lifetime decision.

EXPERIENCE A2P2 DISCUSS ENTERPRISE LICENSING

337 → 71 DAYS

Bioreactor stability programme

£40 MILLION

Avoided waste associated with an adhesive shelf-life extension

8 YEARS

Prediction compared with continuous field service

A live platform for lifetime decisions
A2P2 brings experimental evidence, material-specific calculations, study design and decision records into one governed environment. The protected platform supports workflows spanning DMA-TTS, creep, hydrolysis, oxidation, FTIR, DSC and device-level Q₁₀ analysis.

From material behaviour to a defensible decision.

1 · Define the system

Materials, interfaces, processing, sterilisation and the intended lifetime claim.

2 · Identify the governing behaviour

Select the mechanism and experimental pathway that describe the product actually manufactured.

3 · Calculate and verify

Determine the acceleration factor, study duration, temperature domain and verification plan.

4 · Create the decision record

Connect source data, calculations, acceptance criteria and limitations for review.

Designed for enterprise adoption

A2P2 is not a one-off test. An implementation combines an annual framework and platform licence, a foundational programme around the organisation’s lead system, method transfer, laboratory implementation, team training and defined scientific governance.

The result is an internal capability that becomes more valuable as the governed materials library grows across products and programmes.

EXPLORE THE PUBLIC DEMONSTRATION START A LICENSING DISCUSSION